INCOME TAXES	9 Months Ended
Sep. 30, 2013
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES During the three and nine months ended September 30, 2013, the Company recorded a provision for income taxes of approximately $0.3 million and $1.5 million, respectively. The provision for income taxes primarily consisted of foreign taxes. During the nine months ended September 30, 2012, the benefit for income tax resulted from reducing our domestic deferred tax asset valuation allowance in connection with the eBiosciences acquisition partially offset by a provision for foreign income tax. Due to the Company’s history of cumulative operating losses, management concluded that, after considering all the available objective evidence, it is not more likely than not that all the Company’s net deferred tax assets will be realized. Accordingly, all of the U.S. deferred tax assets continue to be subject to a valuation allowance as of September 30, 2013. As of September 30, 2013, the total amount of unrecognized tax benefits has increased by approximately $0.6 million, primarily due to additional uncertain tax positions for transfer pricing. As a result of settlements of ongoing tax examinations and/or expiration of statutes of limitations without the assessment of additional income taxes, we anticipate the total amount of unrecognized tax benefits that could change in the next 12 months is approximately $2.7 million.

INCOME TAXES

9 Months Ended

Sep. 30, 2013

During the three and nine months ended September 30, 2013, the Company recorded a provision for income taxes of approximately $0.3 million and $1.5 million, respectively. The provision for income taxes primarily consisted of foreign taxes. During the nine months ended September 30, 2012, the benefit for income tax resulted from reducing our domestic deferred tax asset valuation allowance in connection with the eBiosciences acquisition partially offset by a provision for foreign income tax.

Due to the Company’s history of cumulative operating losses, management concluded that, after considering all the available objective evidence, it is not more likely than not that all the Company’s net deferred tax assets will be realized. Accordingly, all of the U.S. deferred tax assets continue to be subject to a valuation allowance as of September 30, 2013.

As of September 30, 2013, the total amount of unrecognized tax benefits has increased by approximately $0.6 million, primarily due to additional uncertain tax positions for transfer pricing. As a result of settlements of ongoing tax examinations and/or expiration of statutes of limitations without the assessment of additional income taxes, we anticipate the total amount of unrecognized tax benefits that could change in the next 12 months is approximately $2.7 million.